Advise to Titian Software on Battery Ventures investment

- Advertisement -

ENGLAND – The corporate team at Penningtons Manches Cooper has advised shareholders of Titian Software, on a significant, majority investment from US tech investment firm Battery Ventures. Tian a sample management software solution provider to the life sciences sector, will use the new funds to support organic growth as well as potential future acquisitions.

Titian’s Mosaic product helps researchers better manage and automate critical processes, allowing customers to maximise research efficiency and speed up the discovery and delivery of new drugs.

Penningtons Manches Cooper have offices in London, Midlands and across the South East of England. Founded in 1983, Battery Ventures backs companies at all stages, ranging from seed and early to growth and buyout. The firm invests globally from six strategic locations: Boston; San Francisco, California, Tel Aviv, London, and New York.

Edmund Wilson, Chief Executive Officer and Founder of Titian Software, comments: “Our new partnership with Battery represents a key inflection point for the company that should allow us to scale even further. With Battery’s help, Titian can better capitalise on the exciting growth opportunities we see ahead in the sample-management sector. I’d like to thank Will Axtell and the team at Penningtons Manches Cooper for their expertise and advice on this strategic deal.”

The corporate team advising Titian Software was led by partner Will Axtell and senior associate Dominique Sabatini with support from associate Lindsay Chadwick. The wider team included support from corporate tax associate Leonie Langley, pensions partner Alison Hills and senior associate Clare Cole, commercial managing associate Edmund Forey and senior associate Susie Hilton Knox, real estate senior associate Giorgia Clements and employment associate Hannah Grayson.

Will Axtell said: “We are delighted to have advised the team at Titian Software on this important cross-border technology transaction. This demonstrates the strength of our life sciences and technology teams as well as our ability to transact complex and large cross-border corporate deals effectively and at pace. We wish Titian all the best for their exciting future with Battery Ventures.”

Hot this week

Algorithmic Bias in Healthcare What the World Can Learn from Kenya’s AI Deployment

The global push for AI in public services is...

Who Will Lead Solomon Islands Next? Political Negotiations Begin After PM Ouster

After Prime Minister Jeremiah Manele, who was also the...

New Blood Test for Glioblastoma Could Replace Risky Brain Surgery, Researchers Say

Healthcare (Commonwealth Union) – Glioblastoma is an extremely aggressive...

The Sky Shift of 2026: How Australia Is Becoming the World’s New Aviation Crossroads

A radical change is occurring in Australia's aviation sector...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories